NCT05766371
- Conditions
- Castrate Resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
Castrate Resistant Prostate Cancer
Explore clinical trials studying Castrate Resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.
14 public trials
6 recruiting studies
Castrate Resistant Prostate Cancer trial results
NCT06395519
- Conditions
- Adnexal Diseases, Advanced or Metastatic Solid Tumors, BRCA Mutation, +52 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Yale University, Yale Cancer Center New Haven, Connecticut, United States
- Mayo Clinic Jacksonville, Florida, United States
- University of Chicago Medical Center Chicago, Illinois, United States
NCT06999187
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +55 more
- Locations
-
- Dren Investigational Site Denver, Colorado, United States
- Dren Investigational Site Orlando, Florida, United States
- Dren Investigational Site Sarasota, Florida, United States
- Dren Investigational Site Huntersville, North Carolina, United States
NCT04969315
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +52 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT06783127
- Conditions
- BRCA Mutation, Castrate Resistant Prostate Cancer, Genital Diseases, +10 more
- Locations
-
- Sabrina Rossetti Naples, Italy
- Orazio Caffo Trento, Italy
NCT05488548
- Conditions
- Bone Marrow Diseases, Castrate Resistant Prostate Cancer, Chronic Disease, +16 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
Enrolling by invitation
177Lu-HTK03170 in mCRPC With PSMA Positive Disease
NCT05570994
- Conditions
- Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
Active, not recruiting
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
NCT04319783
- Conditions
- Advanced Prostate Carcinoma, Cancer Of Prostate, Castrate Resistant Prostate Cancer, +11 more
- Locations
-
- St Vincent's Hospital Darlinghurst, New South Wales, Australia
- GenesisCare Hurstville Hurstville, New South Wales, Australia
- GenesisCare North Shore Saint Leonards, New South Wales, Australia
- Calvary Mater Newcastle Waratah, New South Wales, Australia
NCT04335682
- Conditions
- Castrate Resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +13 more
- Locations
-
- University of California - San Francisco at Mount Zion San Francisco, California, United States
- Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
- University of Chicago Chicago, Illinois, United States
- University of Kansas Cancer Center Fairway, Kansas, United States
Completed
Checkpoint Inhibitors and SBRT for MCRPC
NCT05655715
- Conditions
- Castrate Resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- Department of Oncology, Copenhagen University Hospital Herlev and Gentofte Hospital Herlev, Capital Region, Denmark